These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 34031575)

  • 41. Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches.
    Edwards RL; Menteer J; Lestz RM; Baxter-Lowe LA
    Biomark Med; 2022 Apr; 16(5):401-415. PubMed ID: 35195028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study.
    Osmanodja B; Akifova A; Oellerich M; Beck J; Bornemann-Kolatzki K; Schütz E; Budde K
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation.
    Halloran PF; Reeve J; Madill-Thomsen KS; Kaur N; Ahmed E; Cantos C; Al Haj Baddar N; Demko Z; Liang N; Swenerton RK; Zimmermann BG; Van Hummelen P; Prewett A; Rabinowitz M; Tabriziani H; Gauthier P; Billings P;
    Transplantation; 2022 Dec; 106(12):2435-2442. PubMed ID: 35765145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
    Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population.
    Kumar N; Tandon A; Rana R; Rana DS; Bhalla AK; Gupta A; Sachdeva MP; Huirem RS; Chauhan K; Yashavarddhan MH; Basnal A; Gupta R; Mallick PK; Ganguly NK
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients.
    Dale BL; Bose S; Kuo S; Burns A; Daou P; Short J; Miles J
    JMIR Res Protoc; 2021 Mar; 10(3):e25941. PubMed ID: 33720033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration.
    Lakhani L; Alasfar S; Bhalla A; Aala A; Rosenberg A; Ostrander D; Schollenberger MD; Brennan DC; Lipson EJ
    Transplant Direct; 2021 Feb; 7(2):e656. PubMed ID: 33490381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 50. Association between dd-cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort.
    Sawinski DL; Mehta S; Alhamad T; Bromberg JS; Fischbach B; Aeschbacher T; Ghosh S; Shekhtman G; Dholakia S; Brennan DC; Poggio E; Bloom RD; Jordan SC
    Clin Transplant; 2021 Sep; 35(9):e14402. PubMed ID: 34184326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Observed elevated donor-derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection.
    Afzal A; Alam A; van Zyl JS; Zafar H; Felius J; Hall SA; Carey SA
    Clin Transplant; 2022 Mar; 36(3):e14549. PubMed ID: 34863042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA
    Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical relevance of cell-free DNA quantification and qualification during the first month after lung transplantation.
    Pedini P; Coiffard B; Cherouat N; Casas S; Fina F; Boutonnet A; Baudey JB; Aho P; Basire A; Simon S; Frassati C; Chiaroni J; Reynaud-Gaubert M; Picard C
    Front Immunol; 2023; 14():1183949. PubMed ID: 37180126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant.
    Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ
    Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Donor Derived Cell Free DNA in Kidney Transplantation: The Circa 2020-2021 Update.
    Kant S; Brennan DC
    Transpl Int; 2022; 35():10448. PubMed ID: 35721467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
    Kataria A; Kumar D; Gupta G
    Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local laboratory-run donor-derived cell-free DNA assay for rejection surveillance in heart transplantation-first six months of clinical experience.
    Teszak T; Bödör C; Hegyi L; Levay L; Nagy B; Fintha A; Merkely B; Sax B
    Clin Transplant; 2023 Sep; 37(9):e15078. PubMed ID: 37489087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis.
    Wijtvliet VPWM; Plaeke P; Abrams S; Hens N; Gielis EM; Hellemans R; Massart A; Hesselink DA; De Winter BY; Abramowicz D; Ledeganck KJ
    Transpl Int; 2020 Dec; 33(12):1626-1642. PubMed ID: 32981117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation.
    Mantios E; Filiopoulos V; Constantoulakis P; Liapis G; Vittoraki A; Casas S; Marinaki S; Boletis JN
    Transpl Int; 2023; 36():11507. PubMed ID: 37901296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients.
    Kueng N; Arcioni S; Sandberg F; Kuhn C; Banz V; Largiadèr CR; Sidler D; Amstutz U
    Front Genet; 2023; 14():1089830. PubMed ID: 36777723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.